Cancer drug resistance remains a formidable challenge in modern oncology, necessitating
innovative therapeutic strategies. The convergence of intricate regulatory networks involving …

Triple-negative breast cancer (TNBC) is a more aggressive type of breast cancer due to its
heterogeneity and complex molecular mechanisms. TNBC has a high risk for metastasis …

Abstract Cytochrome P450 3A4 (CYP3A4) is the most important and abundant drug-
metabolizing enzyme in the human liver. Inter-individual differences in the expression and …

Lung cancer ranks among the most lethal types of cancer globally, with a high occurrence
and fatality rate. The spread of cancer to other parts of the body, known as metastasis, is the …

Abstract Objective Long noncoding RNAs (lncRNAs) regulate cancer cell senescence in
many cancers. However, their specific involvement in head and neck squamous cell …

Gastric cancer (GC) is a highly prevalent and deadly malignant neoplasm worldwide.
Currently, long non-coding RNAs (lncRNAs) have recently been identified as crucial …

Having been involved in complex cellular regulatory networks and cell-to-cell
communications, non-coding RNAs (lncRNAs) have become functional carriers that transmit …

Cancer treatment has long been fraught with challenges, including drug resistance,
metastasis, and recurrence, making it one of the most difficult diseases to treat effectively …

Long non-coding RNAs (lncRNAs) are pivotal controllers of gene expression through
epigenetic mechanisms, Methylation, a prominent area of study in epigenetics, significantly …

Triple-negative breast cancer (TNBC) stands as the most complex and daunting subtype of
breast cancer affecting women globally. Regrettably, treatment options for TNBC remain …